BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 15961758)

  • 1. Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin's lymphoma.
    Claviez A; Tiemann M; Lüders H; Krams M; Parwaresch R; Schellong G; Dörffel W
    J Clin Oncol; 2005 Jun; 23(18):4048-56. PubMed ID: 15961758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome.
    Herling M; Rassidakis GZ; Medeiros LJ; Vassilakopoulos TP; Kliche KO; Nadali G; Viviani S; Bonfante V; Giardini R; Chilosi M; Kittas C; Gianni AM; Bonadonna G; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH
    Clin Cancer Res; 2003 Jun; 9(6):2114-20. PubMed ID: 12796376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease.
    Glavina-Durdov M; Jakic-Razumovic J; Capkun V; Murray P
    Br J Cancer; 2001 May; 84(9):1227-34. PubMed ID: 11336475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
    Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
    Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients.
    Diepstra A; van Imhoff GW; Schaapveld M; Karim-Kos H; van den Berg A; Vellenga E; Poppema S
    J Clin Oncol; 2009 Aug; 27(23):3815-21. PubMed ID: 19470931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of Epstein-Barr virus status on clinical outcome in Hodgkin's lymphoma.
    Kwon JM; Park YH; Kang JH; Kim K; Ko YH; Ryoo BY; Lee SS; Lee SI; Koo HH; Kim WS
    Ann Hematol; 2006 Jul; 85(7):463-8. PubMed ID: 16534596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the Epstein-Barr virus encoded latent membrane protein in tumor cells of Hodgkin's disease occurring in childhood.
    Kanavaros P; Sakalidou A; Gaulard P; Jiwa M; Delides G; Tzardi M; Kalmantis T; Lydaki E; Kazlaris E; Kalmanti M
    Acta Morphol Hung; 1992; 40(1-4):223-30. PubMed ID: 1365766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of association of Epstein Barr-virus with Hodgkin's disease.
    Radha K; Shanthi P; Madhavan M; Senthamarai A
    Indian J Pathol Microbiol; 1997 Jul; 40(3):351-4. PubMed ID: 9354006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the Epstein-Barr virus positivity on Hodgkin's lymphoma in a large cohort from a single institute in Korea.
    Koh YW; Yoon DH; Suh C; Huh J
    Ann Hematol; 2012 Sep; 91(9):1403-12. PubMed ID: 22526365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Childhood Hodgkin's disease in the United States: an analysis of histologic subtypes and association with Epstein-Barr virus.
    Andriko JA; Aguilera NS; Nandedkar MA; Abbondanzo SL
    Mod Pathol; 1997 Apr; 10(4):366-71. PubMed ID: 9110300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical detection of Epstein-Barr virus-encoded latent membrane protein in Reed-Sternberg cells and variants of Hodgkin's disease.
    Pinkus GS; Lones M; Shintaku IP; Said JW
    Mod Pathol; 1994 May; 7(4):454-61. PubMed ID: 7520586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study.
    Keegan TH; Glaser SL; Clarke CA; Gulley ML; Craig FE; Digiuseppe JA; Dorfman RF; Mann RB; Ambinder RF
    J Clin Oncol; 2005 Oct; 23(30):7604-13. PubMed ID: 16186595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Epstein-Barr virus latent membrane protein and Hodgkin's disease in Mexico.
    Quintanilla-Martínez L; Gamboa-Domńquez A; Gamez-Ledesma I; Angeles-Angeles A; Mohar A
    Mod Pathol; 1995 Aug; 8(6):675-9. PubMed ID: 8532705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the latent membrane protein of Epstein-Barr virus in Hodgkin's disease. Age and subtype distribution in Polish patients.
    Kordek R; Jesionek-Kupnicka D; Biernat W; Woźniak L
    Acta Haematol Pol; 1996; 27(1):15-20. PubMed ID: 8629438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hodgkin's lymphoma in Indian children: prevalence and significance of Epstein-Barr virus detection in Hodgkin's and Reed-Sternberg cells.
    Dinand V; Dawar R; Arya LS; Unni R; Mohanty B; Singh R
    Eur J Cancer; 2007 Jan; 43(1):161-8. PubMed ID: 17113770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent expression of Epstein-Barr virus latent membrane protein-1 in tumour cells of Hodgkin's disease in HIV-positive patients.
    Audouin J; Diebold J; Pallesen G
    J Pathol; 1992 Aug; 167(4):381-4. PubMed ID: 1328576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus expression in Hodgkin's disease in Jordan.
    Almasri NM; Khalidi HS
    Saudi Med J; 2004 Jun; 25(6):770-5. PubMed ID: 15195209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma.
    Diepstra A; van Imhoff GW; Karim-Kos HE; van den Berg A; te Meerman GJ; Niens M; Nolte IM; Bastiaannet E; Schaapveld M; Vellenga E; Poppema S
    J Clin Oncol; 2007 Jul; 25(21):3101-8. PubMed ID: 17536082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients.
    Spacek M; Hubacek P; Markova J; Zajac M; Vernerova Z; Kamaradova K; Stuchly J; Kozak T
    APMIS; 2011 Jan; 119(1):10-6. PubMed ID: 21143522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.